1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > BRIC Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020

BRIC Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020

Summary

GlobalData’s new report, "BRIC Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020", provides key market data on the BRIC Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures. The report provides procedure volumes within market segments - Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures (ERCP Plastic Biliary Stenting Procedures and ERCP Metal Biliary Stenting Procedures (ERCP Metal - Non-Covered Biliary Stenting Procedures, ERCP Metal - Partially Covered Biliary Stenting Procedures and ERCP Metal - Fully Covered Biliary Stenting Procedures)) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures without Stenting.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- Procedure volumes by segment - Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures (ERCP Plastic Biliary Stenting Procedures and ERCP Metal Biliary Stenting Procedures (ERCP Metal - Non-Covered Biliary Stenting Procedures, ERCP Metal - Partially Covered Biliary Stenting Procedures and ERCP Metal - Fully Covered Biliary Stenting Procedures)) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures without Stenting.
- Projections for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.

Table Of Contents

BRIC Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Segmentation 6
2.3 Definitions of Procedures Covered in the Report 7
3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, BRIC 8
3.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, BRIC, 2005-2020 8
3.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, BRIC, 2005-2020, Category Comparison by Procedures, 2005-2020 10
3.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, BRIC, 2005-2013 12
3.4 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, BRIC, 2013-2020 14
4 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Brazil 16
4.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Brazil, 2005-2013 16
4.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Brazil, 2013-2020 18
4.2.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Brazil, 2005-2013 20
4.2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Brazil, 2013-2020 22
4.2.2.1 ERCP Metal Biliary Stenting Procedures, Brazil, 2005-2013 24
4.2.2.2 ERCP Metal Biliary Stenting Procedures, Brazil, 2013-2020 26
5 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Russia 28
5.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Russia, 2005-2013 28
5.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Russia, 2013-2020 30
5.2.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Russia, 2005-2013 32
5.2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Russia, 2013-2020 34
5.2.2.1 ERCP Metal Biliary Stenting Procedures, Russia, 2005-2013 36
5.2.2.2 ERCP Metal Biliary Stenting Procedures, Russia, 2013-2020 38
6 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, India 40
6.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, India, 2005-2013 40
6.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, India, 2013-2020 42
6.2.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, India, 2005-2013 44
6.2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, India, 2013-2020 46
6.2.2.1 ERCP Metal Biliary Stenting Procedures, India, 2005-2013 48
6.2.2.2 ERCP Metal Biliary Stenting Procedures, India, 2013-2020 50
7 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, China 52
7.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, China, 2005-2013 52
7.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, China, 2013-2020 54
7.2.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, China, 2005-2013 56
7.2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, China, 2013-2020 58
7.2.2.1 ERCP Metal Biliary Stenting Procedures, China, 2005-2013 60
7.2.2.2 ERCP Metal Biliary Stenting Procedures, China, 2013-2020 62
8 Appendix 64
8.1 Research Methodology 65
8.1.1 Coverage 65
8.1.2 Secondary Research 65
8.1.3 Primary Research 66
8.1.4 Market Modeling and Forecasting 67
8.1.5 Company Share Analysis 70
8.1.6 Distribution Share Analysis 71
8.2 Expert Panel 71
8.3 GlobalData Consulting 72
8.4 Contact Us 72
8.5 Disclaimer 72

1.1 List of Tables
Table 1: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, BRIC, 2005-2020 9
Table 2: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, BRIC, 2005-2020, Category Comparison by Procedures, 2005-2020 11
Table 3: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, BRIC, Historic, 2005-2013 13
Table 4: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, BRIC, Forecast, 2013-2020 15
Table 5: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Brazil, Historic, 2005-2013 17
Table 6: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Brazil, Forecast, 2013-2020 19
Table 7: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Brazil, Historic, 2005-2013 21
Table 8: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Brazil, Forecast, 2013-2020 23
Table 9: ERCP Metal Biliary Stenting Procedures, Brazil, Historic, 2005-2013 25
Table 10: ERCP Metal Biliary Stenting Procedures, Brazil, Forecast, 2013-2020 27
Table 11: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Russia, Historic, 2005-2013 29
Table 12: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Russia, Forecast, 2013-2020 31
Table 13: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Russia, Historic, 2005-2013 33
Table 14: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Russia, Forecast, 2013-2020 35
Table 15: ERCP Metal Biliary Stenting Procedures, Russia, Historic, 2005-2013 37
Table 16: ERCP Metal Biliary Stenting Procedures, Russia, Forecast, 2013-2020 39
Table 17: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, India, Historic, 2005-2013 41
Table 18: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, India, Forecast, 2013-2020 43
Table 19: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, India, Historic, 2005-2013 45
Table 20: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, India, Forecast, 2013-2020 47
Table 21: ERCP Metal Biliary Stenting Procedures, India, Historic, 2005-2013 49
Table 22: ERCP Metal Biliary Stenting Procedures, India, Forecast, 2013-2020 51
Table 23: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, China, Historic, 2005-2013 53
Table 24: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, China, Forecast, 2013-2020 55
Table 25: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, China, Historic, 2005-2013 57
Table 26: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, China, Forecast, 2013-2020 59
Table 27: ERCP Metal Biliary Stenting Procedures, China, Historic, 2005-2013 61
Table 28: ERCP Metal Biliary Stenting Procedures, China, Forecast, 2013-2020 63
Table 29: Total Number of Primary Research Participants, General Surgery Market, by Country 67

1.2 List of Figures
Figure 1: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, BRIC, 2005-2020 8
Figure 2: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, BRIC, 2005-2020, Category Comparison by Procedures, 2005-2020 10
Figure 3: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, BRIC, Historic, 2005-2013 12
Figure 4: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, BRIC, Forecast, 2013-2020 14
Figure 5: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Brazil, Historic, 2005-2013 16
Figure 6: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Brazil, Forecast, 2013-2020 18
Figure 7: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Brazil, Historic, 2005-2013 20
Figure 8: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Brazil, Forecast, 2013-2020 22
Figure 9: ERCP Metal Biliary Stenting Procedures, Brazil, Historic, 2005-2013 24
Figure 10: ERCP Metal Biliary Stenting Procedures, Brazil, Forecast, 2013-2020 26
Figure 11: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Russia, Historic, 2005-2013 28
Figure 12: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Russia, Forecast, 2013-2020 30
Figure 13: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Russia, Historic, 2005-2013 32
Figure 14: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Russia, Forecast, 2013-2020 34
Figure 15: ERCP Metal Biliary Stenting Procedures, Russia, Historic, 2005-2013 36
Figure 16: ERCP Metal Biliary Stenting Procedures, Russia, Forecast, 2013-2020 38
Figure 17: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, India, Historic, 2005-2013 40
Figure 18: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, India, Forecast, 2013-2020 42
Figure 19: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, India, Historic, 2005-2013 44
Figure 20: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, India, Forecast, 2013-2020 46
Figure 21: ERCP Metal Biliary Stenting Procedures, India, Historic, 2005-2013 48
Figure 22: ERCP Metal Biliary Stenting Procedures, India, Forecast, 2013-2020 50
Figure 23: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, China, Historic, 2005-2013 52
Figure 24: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, China, Forecast, 2013-2020 54
Figure 25: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, China, Historic, 2005-2013 56
Figure 26: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, China, Forecast, 2013-2020 58
Figure 27: ERCP Metal Biliary Stenting Procedures, China, Historic, 2005-2013 60
Figure 28: ERCP Metal Biliary Stenting Procedures, China, Forecast, 2013-2020 62
Figure 29: GlobalData Epidemiology-Based Forecasting Model 69
Figure 30: GlobalData Capital Equipment-Based Forecasting Model 70
Figure 31: Primary Interviews by Participant Type (%) 71

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.